Offer - Urjas Oil for just ₹ 1 X
Wosulin 30/70 Suspension for Injection 100 IU/ml is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Diabetes Type 1, Diabetes Type 1. Wosulin 30/70 Suspension for Injection 100 IU/ml also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Wosulin 30/70 Suspension for Injection 100 IU/ml. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Wosulin 30/70 Suspension for Injection 100 IU/ml can also lead to other problems, which have been listed below. Usually, these side effects of Wosulin 30/70 Suspension for Injection 100 IU/ml go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Wosulin 30/70 Suspension for Injection 100 IU/ml is Safe for pregnant women and Unknown for women who are breastfeeding. Warnings related to Wosulin 30/70 Suspension for Injection 100 IU/ml's effects on the liver, heart and kidney, if any, have been listed below.
The section on Wosulin 30/70 Suspension for Injection 100 IU/ml contraindications lists all such conditions.
Additionally, Wosulin 30/70 Suspension for Injection 100 IU/ml may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Wosulin 30/70 Suspension for Injection 100 IU/ml, it is important to know that it is safe while driving, and is habit-forming.
Wosulin 30/70 Suspension for Injection 100 IU/ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Wosulin 30/70 Suspension for Injection 100 IU/ml safe for pregnant women?
Wosulin is safe for pregnant women.
Is the use of Wosulin 30/70 Suspension for Injection 100 IU/ml safe during breastfeeding?
Information about safety of Wosulin for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Wosulin 30/70 Suspension for Injection 100 IU/ml on the Kidneys?
Wosulin may have mild side effects on the kidneys.
What is the effect of Wosulin 30/70 Suspension for Injection 100 IU/ml on the Liver?
Very few cases of side effects of Wosulin on the liver have been reported.
What is the effect of Wosulin 30/70 Suspension for Injection 100 IU/ml on the Heart?
Very few cases of side effects of Wosulin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Wosulin 30/70 Suspension for Injection 100 IU/ml unless your doctor advises you to do so -
Is this Wosulin 30/70 Suspension for Injection 100 IU/ml habit forming or addictive?
No, you will not get addicted to Wosulin 30/70 Suspension for Injection 100 IU/ml.
Interaction between Food and Wosulin 30/70 Suspension for Injection 100 IU/ml
There is no information on the effects of taking Wosulin 30/70 Suspension for Injection 100 IU/ml with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Wosulin 30/70 Suspension for Injection 100 IU/ml
Drinking alcohol while taking Wosulin 30/70 Suspension for Injection 100 IU/ml may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Novolin® N (Human Insulin Isophane)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® N (Human Insulin Isophane)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 693-695
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® R (regular insulin human)